Legis Daily

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

USA116th CongressHR-220| House 
| Updated: 1/25/2019
Christopher H. Smith

Christopher H. Smith

Republican Representative

New Jersey

Cosponsors (21)
John Katko (Republican)Elise M. Stefanik (Republican)Tom Malinowski (Democratic)Brian Higgins (Democratic)Kathleen M. Rice (Democratic)Max Rose (Democratic)Jackie Walorski (Republican)Collin C. Peterson (Democratic)Ann M. Kuster (Democratic)Sean Patrick Maloney (Democratic)Mike Kelly (Republican)Filemon Vela (Democratic)Chris Collins (Republican)Antonio Delgado (Democratic)Yvette D. Clarke (Democratic)Vicky Hartzler (Republican)Albio Sires (Democratic)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Zoe Lofgren (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019 This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group. The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must: support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders; establish a surveillance system to track the prevalence of such diseases and disorders in humans; establish a surveillance system to track the prevalence of disease-carrying ticks; conduct educational campaigns; and hold a series of research symposiums.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 3, 2019
Introduced in House
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 3, 2019
    Introduced in House


  • January 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.

Health

Congressional oversightDepartment of Health and Human ServicesExecutive agency funding and structureHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseasesMedical educationMedical researchMedical tests and diagnostic methodsResearch administration and fundingScientific communication

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

USA116th CongressHR-220| House 
| Updated: 1/25/2019
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019 This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group. The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must: support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders; establish a surveillance system to track the prevalence of such diseases and disorders in humans; establish a surveillance system to track the prevalence of disease-carrying ticks; conduct educational campaigns; and hold a series of research symposiums.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 3, 2019
Introduced in House
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 3, 2019
    Introduced in House


  • January 3, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.
Christopher H. Smith

Christopher H. Smith

Republican Representative

New Jersey

Cosponsors (21)
John Katko (Republican)Elise M. Stefanik (Republican)Tom Malinowski (Democratic)Brian Higgins (Democratic)Kathleen M. Rice (Democratic)Max Rose (Democratic)Jackie Walorski (Republican)Collin C. Peterson (Democratic)Ann M. Kuster (Democratic)Sean Patrick Maloney (Democratic)Mike Kelly (Republican)Filemon Vela (Democratic)Chris Collins (Republican)Antonio Delgado (Democratic)Yvette D. Clarke (Democratic)Vicky Hartzler (Republican)Albio Sires (Democratic)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Zoe Lofgren (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDepartment of Health and Human ServicesExecutive agency funding and structureHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseasesMedical educationMedical researchMedical tests and diagnostic methodsResearch administration and fundingScientific communication